How much profit has Abcam made this year?
Abcam has made 108.91 M GBP this year.
Abcam Net Income 2024
Abcam Net Income
108.91 M GBP
Ticker
ABC.L
ISIN
GB00B6774699
WKN
A1C605
In 2024, Abcam's profit amounted to 108.91 M GBP, a 25.57% increase from the 86.73 M GBP profit recorded in the previous year.
The Abcam Net Income history
| YEAR | NET INCOME (undefined GBP) |
|---|---|
| 2026e | 164.27 |
| 2025e | 129.48 |
| 2025e | 228.92 |
| 2024e | 108.91 |
| 2023e | 86.73 |
| 2022e | 69.4 |
| 2021 | 17.2 |
| 2020 | 16.2 |
| 2019 | 12.5 |
| 2018 | 45 |
| 2017 | 62.2 |
| 2016 | 42.36 |
| 2015 | 37.43 |
| 2014 | 37.38 |
| 2013 | 34 |
| 2012 | 32.7 |
| 2011 | 25.4 |
| 2010 | 23.8 |
| 2009 | 19.2 |
| 2008 | 12.3 |
| 2007 | 5.9 |
| 2006 | 4.1 |
| 2005 | 3.7 |
| 2004 | 2.3 |
| 2003 | 1 |
| 2002 | 0.5 |
Abcam Revenue, EBIT, Net Income GB00B6774699 · A1C605
3 years
5 years
10 years
25 Years
Max
Revenue
EBIT
Net Income
Details
Revenue, EBIT and Profit
ⓘUnderstanding Revenue, EBIT, and Income
Gain insights into Abcam, a comprehensive overview of its financial performance can be obtained by analyzing the Revenue, EBIT, and Income chart. Revenue represents the total income generated by Abcam from its primary operations, showcasing the company’s ability to attract and retain clients. EBIT, or Earnings Before Interest and Taxes, indicates the company’s operational profitability, free from the influence of tax and interest expenses. The Income section reflects Abcam’s net earnings, an ultimate measure of its financial health and profitability.
Yearly Analysis and Comparisons
Observe the yearly bars to understand the annual performance and growth of Abcam. Compare the Revenue, EBIT, and Income to evaluate the company’s efficiency and profitability. A higher EBIT compared to the previous year suggests an improvement in operational efficiency. Likewise, an increase in Income indicates enhanced overall profitability. Analyzing the year-to-year comparison assists investors in understanding the company’s growth trajectory and operational efficiency.
Utilizing Expectations for Investment
The expected values for the forthcoming years offer investors a glimpse into Abcam’s anticipated financial performance. Analyzing these projections alongside historical data aids in making informed investment decisions. Investors can gauge the potential risks and returns, aligning their investment strategies accordingly to optimize profitability and mitigate risks.
Investment Insights
Leveraging the comparison between Revenue and EBIT helps in assessing Abcam’s operational efficiency, while the Revenue and Income comparison reveals the net profitability after accounting for all expenses. Investors can derive valuable insights by meticulously analyzing these financial parameters, laying the foundation for strategic investment decisions aimed at capitalizing on Abcam’s growth potential.
Abcam Revenue, EBIT and net profit per share
| Date | Abcam Revenue | Abcam EBIT | Abcam Net Income |
|---|---|---|---|
| 2026e | 615.41 M undefined | 214.31 M undefined | 164.27 M undefined |
| 2025e | 545.23 M undefined | 166.51 M undefined | 129.48 M undefined |
| 2025e | 475.19 M undefined | 0 undefined | 228.92 M undefined |
| 2024e | 509.86 M undefined | 149.47 M undefined | 108.91 M undefined |
| 2023e | 453.03 M undefined | 118.42 M undefined | 86.73 M undefined |
| 2022e | 398.46 M undefined | 80.53 M undefined | 69.4 M undefined |
| 2021 | 462.9 M undefined | 50 M undefined | 17.2 M undefined |
| 2020 | 297.7 M undefined | 37.4 M undefined | 16.2 M undefined |
| 2019 | 260 M undefined | 35.9 M undefined | 12.5 M undefined |
| 2018 | 259.9 M undefined | 77.1 M undefined | 45 M undefined |
| 2017 | 233.2 M undefined | 81.3 M undefined | 62.2 M undefined |
| 2016 | 217.1 M undefined | 59.57 M undefined | 42.36 M undefined |
| 2015 | 171.67 M undefined | 50.27 M undefined | 37.43 M undefined |
| 2014 | 144.03 M undefined | 45.73 M undefined | 37.38 M undefined |
| 2013 | 128 M undefined | 43.3 M undefined | 34 M undefined |
| 2012 | 122.2 M undefined | 42.8 M undefined | 32.7 M undefined |
| 2011 | 97.8 M undefined | 34.2 M undefined | 25.4 M undefined |
| 2010 | 83.3 M undefined | 31.7 M undefined | 23.8 M undefined |
| 2009 | 71.1 M undefined | 25.6 M undefined | 19.2 M undefined |
| 2008 | 56.8 M undefined | 17.2 M undefined | 12.3 M undefined |
| 2007 | 36.7 M undefined | 7.4 M undefined | 5.9 M undefined |
| 2006 | 24.5 M undefined | 5.2 M undefined | 4.1 M undefined |
| 2005 | 19.4 M undefined | 4.6 M undefined | 3.7 M undefined |
| 2004 | 12.1 M undefined | 2.9 M undefined | 2.3 M undefined |
| 2003 | 6.7 M undefined | 1.4 M undefined | 1 M undefined |
| 2002 | 3.5 M undefined | 600,000 undefined | 500,000 undefined |
| Revenue | EBIT | Net Income | |
|---|---|---|---|
| 2002 | 3.5 M GBP | 600,000 GBP | 500,000 GBP |
| 2003 | 6.7 M GBP | 1.4 M GBP | 1 M GBP |
| 2004 | 12.1 M GBP | 2.9 M GBP | 2.3 M GBP |
| 2005 | 19.4 M GBP | 4.6 M GBP | 3.7 M GBP |
| 2006 | 24.5 M GBP | 5.2 M GBP | 4.1 M GBP |
| 2007 | 36.7 M GBP | 7.4 M GBP | 5.9 M GBP |
| 2008 | 56.8 M GBP | 17.2 M GBP | 12.3 M GBP |
| 2009 | 71.1 M GBP | 25.6 M GBP | 19.2 M GBP |
| 2010 | 83.3 M GBP | 31.7 M GBP | 23.8 M GBP |
| 2011 | 97.8 M GBP | 34.2 M GBP | 25.4 M GBP |
| 2012 | 122.2 M GBP | 42.8 M GBP | 32.7 M GBP |
| 2013 | 128 M GBP | 43.3 M GBP | 34 M GBP |
| 2014 | 144.03 M GBP | 45.73 M GBP | 37.38 M GBP |
| 2015 | 171.67 M GBP | 50.27 M GBP | 37.43 M GBP |
| 2016 | 217.1 M GBP | 59.57 M GBP | 42.36 M GBP |
| 2017 | 233.2 M GBP | 81.3 M GBP | 62.2 M GBP |
| 2018 | 259.9 M GBP | 77.1 M GBP | 45 M GBP |
| 2019 | 260 M GBP | 35.9 M GBP | 12.5 M GBP |
| 2020 | 297.7 M GBP | 37.4 M GBP | 16.2 M GBP |
| 2021 | 462.9 M GBP | 50 M GBP | 17.2 M GBP |
| 2022e | 398.46 M GBP | 80.53 M GBP | 69.4 M GBP |
| 2023e | 453.03 M GBP | 118.42 M GBP | 86.73 M GBP |
| 2024e | 509.86 M GBP | 149.47 M GBP | 108.91 M GBP |
| 2025e | 475.19 M GBP | 0 GBP | 228.92 M GBP |
| 2025e | 545.23 M GBP | 166.51 M GBP | 129.48 M GBP |
| 2026e | 615.41 M GBP | 214.31 M GBP | 164.27 M GBP |
Abcam stock margins GB00B6774699 · A1C605
The Abcam margin analysis displays the gross margin, EBIT margin, as well as the profit margin of Abcam. The EBIT margin (EBIT/sales) indicates the percentage of sales that remains as operating profit. The profit margin shows the percentage of sales that remains for Abcam.
3 years
5 years
10 years
25 Years
Max
Gross margin
EBIT margin
Profit margin
Details
Margin
ⓘUnderstanding Gross Margin
The gross margin, expressed as a percentage, delineates the gross profit made from the Abcam's sales revenue. A higher gross margin percentage indicates that the Abcam retains more revenue after accounting for the costs of goods sold. Investors use this metric to gauge financial health and operational efficiency, as well as to compare it with competitors and industry averages.
EBIT Margin Analysis
EBIT margin represents the Abcam's earnings before interest and taxes. Analyzing the EBIT margin over different years provides insights into the operational profitability and efficiency, excluding the effects of financial leverage and tax structure. A growing EBIT margin over the years signifies improving operational performance.
Revenue Margin Insights
The revenue margin demonstrates the Abcam's total revenue generated. When comparing the revenue margin year over year, investors can gauge the Abcam's growth and market expansion. It is essential to compare the revenue margin with the gross and EBIT margins to understand the cost and profit structures better.
Interpreting Expectations
The expected values for gross, EBIT, and revenue margins provide future financial outlook of the Abcam. Investors should compare these expectations with historical data to understand potential growth and risk factors. It is crucial to consider the underlying assumptions and methodologies used in projecting these expected values to make informed investment decisions.
Comparative Analysis
Comparing the gross, EBIT, and revenue margins, both yearly and over multiple years, enables investors to perform a comprehensive analysis of the Abcam's financial health and growth prospects. Evaluating the trends and patterns in these margins helps in identifying strengths, weaknesses, and potential investment opportunities.
Abcam Margin History
| Abcam Gross margin | Abcam Profit margin | Abcam EBIT margin | Abcam Profit margin |
|---|---|---|---|
| 2026e | 71.12 % | 34.82 % | 26.69 % |
| 2025e | 71.12 % | 30.54 % | 23.75 % |
| 2025e | 71.12 % | 0 % | 48.18 % |
| 2024e | 71.12 % | 29.32 % | 21.36 % |
| 2023e | 71.12 % | 26.14 % | 19.14 % |
| 2022e | 71.12 % | 20.21 % | 17.42 % |
| 2021 | 71.12 % | 10.8 % | 3.72 % |
| 2020 | 71.15 % | 12.56 % | 5.44 % |
| 2019 | 69.31 % | 13.81 % | 4.81 % |
| 2018 | 70.49 % | 29.67 % | 17.31 % |
| 2017 | 69.9 % | 34.86 % | 26.67 % |
| 2016 | 70.06 % | 27.44 % | 19.51 % |
| 2015 | 70.21 % | 29.28 % | 21.8 % |
| 2014 | 70.49 % | 31.75 % | 25.96 % |
| 2013 | 70.63 % | 33.83 % | 26.56 % |
| 2012 | 70.95 % | 35.02 % | 26.76 % |
| 2011 | 69.12 % | 34.97 % | 25.97 % |
| 2010 | 67.23 % | 38.06 % | 28.57 % |
| 2009 | 66.67 % | 36.01 % | 27 % |
| 2008 | 65.85 % | 30.28 % | 21.65 % |
| 2007 | 60.76 % | 20.16 % | 16.08 % |
| 2006 | 59.18 % | 21.22 % | 16.73 % |
| 2005 | 61.34 % | 23.71 % | 19.07 % |
| 2004 | 61.98 % | 23.97 % | 19.01 % |
| 2003 | 62.69 % | 20.9 % | 14.93 % |
| 2002 | 60 % | 17.14 % | 14.29 % |
| Gross margin | EBIT margin | Profit margin | |
|---|---|---|---|
| 2002 | 60 % | 17.14 % | 14.29 % |
| 2003 | 62.69 % | 20.9 % | 14.93 % |
| 2004 | 61.98 % | 23.97 % | 19.01 % |
| 2005 | 61.34 % | 23.71 % | 19.07 % |
| 2006 | 59.18 % | 21.22 % | 16.73 % |
| 2007 | 60.76 % | 20.16 % | 16.08 % |
| 2008 | 65.85 % | 30.28 % | 21.65 % |
| 2009 | 66.67 % | 36.01 % | 27 % |
| 2010 | 67.23 % | 38.06 % | 28.57 % |
| 2011 | 69.12 % | 34.97 % | 25.97 % |
| 2012 | 70.95 % | 35.02 % | 26.76 % |
| 2013 | 70.63 % | 33.83 % | 26.56 % |
| 2014 | 70.49 % | 31.75 % | 25.96 % |
| 2015 | 70.21 % | 29.28 % | 21.8 % |
| 2016 | 70.06 % | 27.44 % | 19.51 % |
| 2017 | 69.9 % | 34.86 % | 26.67 % |
| 2018 | 70.49 % | 29.67 % | 17.31 % |
| 2019 | 69.31 % | 13.81 % | 4.81 % |
| 2020 | 71.15 % | 12.56 % | 5.44 % |
| 2021 | 71.12 % | 10.8 % | 3.72 % |
| 2022e | 71.12 % | 20.21 % | 17.42 % |
| 2023e | 71.12 % | 26.14 % | 19.14 % |
| 2024e | 71.12 % | 29.32 % | 21.36 % |
| 2025e | 71.12 % | 0 % | 48.18 % |
| 2025e | 71.12 % | 30.54 % | 23.75 % |
| 2026e | 71.12 % | 34.82 % | 26.69 % |
Abcam Aktienanalyse
What does Abcam do?
Abcam PLC is an internationally operating company specializing in the development, manufacturing, and distribution of antibodies and other reagents for life science research. History: Abcam was founded in 1998 by Jonathan Milner, a biologist and cancer researcher who had experienced using antibodies in research. Recognizing a need for high-quality and reliable reagents in this field, he decided to start his own company. In the years following its founding, Abcam grew rapidly and established itself as one of the leading providers of antibodies. In 2005, the company went public on the London Stock Exchange, raising capital for further expansion. Since then, Abcam has made numerous acquisitions and expanded its product portfolio. Business model: Abcam's business model is based on selling antibodies and other reagents to research institutions, universities, and pharmaceutical companies. The company relies on an extensive network of suppliers and partners to offer a wide range of products. Another important aspect of the business model is the online marketing of Abcam's products. The company operates several websites where customers can browse and order the entire product range. To better understand customer needs, Abcam also conducts regular customer surveys and feedback. Divisions: Abcam offers a wide range of products and services, which are grouped into various divisions: Antibodies: The antibodies division is Abcam's core area, encompassing a variety of monoclonal and polyclonal antibodies for various applications. Proteins: Abcam also offers a wide range of proteins for research in areas such as cancer, neurology, and metabolic diseases. Reagents: In addition to antibodies and proteins, Abcam provides a variety of reagents, including kits for biomarker or enzyme activity determination. Services: Abcam also offers a range of services, including custom antibody development, protein expression, and assay development. Products: Abcam offers a wide range of products for use in various areas of life science research. Some of the most well-known products include: Rabbit monoclonal antibodies: These antibodies are highly specific and sensitive, making them valuable tools in cancer research. Chromatin & nucleic acid purification kits: These kits enable efficient purification of DNA, RNA, and chromatin, which is essential for many genomic and epigenomic applications. ELISA kits: Abcam offers a variety of ELISA kits for the determination of biomarkers and other target molecules. Overall, Abcam is a leading provider of antibodies and other reagents for life science research. Through constant innovation and expansion, the company has successfully grown its business in recent years and is now well-positioned worldwide. Abcam ist eines der beliebtesten Unternehmen auf Eulerpool.com.Net Income Details
Understanding Abcam's Profit Margins
The profit margins of Abcam represent the net income earned after deducting all operational expenses, costs, and taxes from the revenue. This figure is a clear indicator of Abcam's financial health, operational efficiency, and profitability. Higher profit margins signify better cost management and income generation capabilities.
Year-to-Year Comparison
Evaluating Abcam's profit on a yearly basis can offer significant insights into its financial growth, stability, and trends. A consistent increase in profit suggests improved operational efficiency, cost management, or increased revenue, while a decrease may indicate rising costs, declining sales, or operational challenges.
Impact on Investments
Abcam's profit figures are critical for investors who are aiming to understand the company's financial standing and future growth prospects. Increased profits often lead to higher stock valuations, boosting investor confidence and attracting more investments.
Interpreting Profit Fluctuations
When Abcam’s profit increases, it often indicates enhanced operational efficiency or increased sales. In contrast, a decline in profit can signal operational inefficiencies, increased costs, or competitive pressures, necessitating strategic interventions to boost profitability.
Frequently Asked Questions about Abcam stock
How has the profit developed compared to last year?
The profit has increased by 25.57% compared to last year increased
What impact do the earnings have on the shareholders?
An increase in earnings is usually seen as a positive indicator for shareholders as it means that the company is generating profits.
How does Abcam publish its earnings?
Abcam publishes its earnings in the form of quarterly or annual reports.
Which financial indicators are included in the quarterly or annual reports?
The quarterly or annual reports contain information about sales and profit, cash flow, balance sheet, and other fundamentals.
Why is it important for investors to know the earnings of Abcam?
The profits of Abcam are an important indicator of the financial health of the company and can help investors decide whether they want to invest in the company or not.
How can one learn more about the earnings of Abcam?
You can learn more about the earnings of Abcam by reviewing the quarterly or annual reports or following the company presentations.
How much dividend does Abcam pay?
Over the past 12 months, Abcam paid a dividend of 0.04 GBP . This corresponds to a dividend yield of about 0.29 %. For the coming 12 months, Abcam is expected to pay a dividend of 1.05 GBP.
What is the dividend yield of Abcam?
The current dividend yield of Abcam is 0.29 %.
When does Abcam pay dividends?
Abcam pays a quarterly dividend. This is distributed in the months of December, April, December, April.
How secure is the dividend of Abcam?
Abcam paid dividends every year for the past 6 years.
What is the dividend of Abcam?
For the upcoming 12 months, dividends amounting to 1.05 GBP are expected. This corresponds to a dividend yield of 8.54 %.
In which sector is Abcam located?
Abcam is assigned to the 'Health' sector.
Wann musste ich die Aktien von Abcam kaufen, um die vorherige Dividende zu erhalten?
To receive the latest dividend of Abcam from 4/17/2020 amounting to 0.036 GBP, you needed to have the stock in your portfolio before the ex-date on 3/19/2020.
When did Abcam pay the last dividend?
The last dividend was paid out on 4/17/2020.
What was the dividend of Abcam in the year 2023?
In the year 2023, Abcam distributed 0.361 GBP as dividends.
In which currency does Abcam pay out the dividend?
The dividends of Abcam are distributed in GBP.
Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.
The Abcam stock can be added to a savings plan with the following providers: Trade Republic
Andere Kennzahlen von Abcam
Our stock analysis for Abcam Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Abcam Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.
